Roivant Sciences (NASDAQ:ROIV – Get Rating) had its price objective raised by HC Wainwright from $14.00 to $15.00 in a report issued on Wednesday morning, The Fly reports. ROIV has been the topic of several other reports. The Goldman Sachs Group lifted their price objective on Roivant Sciences from $10.00 to $11.00 and gave the […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) CAO Rakhi Kumar sold 15,517 shares of the stock in a transaction dated Tuesday, May 2nd. The shares were sold at an average price of $8.42, for a total value of $130,653.14. Following the completion of the transaction, the chief accounting officer now owns 200,139 shares of the […]
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) have been assigned a consensus recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in […]
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) hit a new 52-week high during mid-day trading on Friday after Citigroup raised their price target on the stock from $11.00 to $14.00. Citigroup currently has a buy rating on the stock. Roivant Sciences traded as high as $9.08 and last traded at $8.87, with a […]